Abstract
The UN conventions present the international legal framework; they urge member states to provide treatment and rehabilitation but prohibit consumption and possession of scheduled drugs. This creates problems for providing treatment and harm reduction programs to patients who are not or not yet ready to stop illicit drug use. Other international documents, notably from the World Health Organization and the United Nations Office on Drugs and Crime, are strongly in favor of agonist substitution treatment and harm reduction measures. Within this framework, national legislation has much room for diverse preferences; the International Narcotic Control Board regularly comments the national practices, as well as the European Monitoring Centre for Drugs and Drug Addiction for the EU member states. An international trend gradually prefers therapeutic measures over criminal sanctions for drug users.
The international ethical framework is set by the universal declaration and European convention on human rights, striking a balance between individual rights and societal interests. Less ambiguous guidance comes from medical ethics claiming the full range of patient’s rights for addicted persons. The respective conduct codes for medical professions are regional or national and include procedures how to deal with ethical conflicts. Conflicting situations frequently occur, e.g., around the principles of autonomy or of confidentiality.
An essential ethical element of treatment is its effectiveness and avoidance of harm, asking for scientific evaluation of therapeutic approaches, services, and systems. The ethical acceptability of agonist substitution treatment and of harm reduction measures is based on rigorous evidence of their effectiveness. Other aspects concern the limits of social acceptability of addictive behavior and the limits of what can be attained for an individual patient by therapeutic interventions; avoidance of harm often is the more immediate objective than full recovery. In a public health perspective, effects at population level rather than at individual level are a priority, aiming at good coverage of treatment needs by good accessibility and affordability of services.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AMA (2001) Principles of medical ethics. In: Code of medical ethics. American Medical Association, Chicago
APA (2000) Diagnostic and statistical manual of mental disorders DSM IV TR. American Psychiatric Association, Arlington
Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence: an international review. Praeger, New York
Arosemena G (2013) Conflicts of rights in international human rights: a meta-rule analysis. Glob Const 2:6–36
Bergmark A (2008) Specific and contextual treatment mechanisms. Nordic Stud Alcohol Drugs 25:277–285
Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, Fry-Smith A, Day E, Lintzeris N, Roberts T, Burls A, Taylor RS (2007) Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess 11:1–171
Council of Europe (1950) Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine. Council of Europe, Rome
Department of Health (2002) Models of care for substance misuse treatment. Promoting quality, efficiency and effectiveness in drug misuse treatment services. Department of Health, London
Dole VP, Nyswander ME (1965) A medical treatment for diacetyl-morphine (heroin) addiction. JAMA 193:646–650
Edlin BR, Keal KH, Lorwock J, Kral AH, Ciccarone DH, Moore LD, Lo B (2001) Is it justifiable to withhold treatment for hepatitis C from illicit drug users? New Engl J Med 345:211–215
Edwards G, Arif A (1980) Dug problems in a socio-cultural context. A basis for policy and programme planning. Public health papers no. 73. World Health Organisation, Geneva
Ekendahl M (2007) Will and skill – an exploratory study of substance abuser’s attitudes towards life-style changes. Eur Addict Res 13:148–155
Elliot HM (1920) Memoirs of Jahangir. Islamic Book Service, Lahore
Emcdda (2009) Special issue 2009. Drug offences; sentencing and other outcomes. European Monitoring Centre on Drugs and Drug Addiction, Lisbon. www.emcdda.europa.eu/publications/selected-issues/sentencing-statistics. Accessed 14 Feb 2013
EMCDDA (2012) www.emcdda.europa.eu/publications/country-overviews
EU (2005) EU drug action plan. Brussels, Amtsblatt der Europäischen Union 2005/C168/01
Farrell M, Ward J, Mattick R, Hall W, Stimson GV, des Jarlais D, Gossop M, Strang J (2004) Methadone maintenance treatment in opiate dependence: a review. Brit Med J 309:997–1001
Fireman M, Rabkin JM (2001) Outcome of liver transplantation in patients with alcohol and other. Chemical dependence. Psychosomatics 42:172–173
Freud S (1884). Ăœber Coca. Centralblatt fĂ¼r die gesamte Therapie 2:289–314
General Medical Council (2006) Good medical practice. Regulating doctors. Ensuring good medical practice. General Medical Council, London
Gerdner A (1998) Patient and programme factors with impact on outcome in Swedish compulsory care of addicts: a systematic review. Lund University, Sweden
Gerstein DR, Datta AR, Ingels JS, Johnson RA, Rasinski KA, Schildhaus S, Talley K (1997) NTIES. The National Treatment Improvement Evaluation Study. Final report. National Opinion Research Center, Chicago
Gossop M (2006) Treating drug misuse problems: evidence of effectiveness. National Treatment Agency for Substance Misuse, London
Gossop M, Marsden J, Stewart D, Kidd T (2003) The National Treatment Outcome Research Study (NTORS): 4–5 year follow-up results. Addiction 98:291–303
Health Canada (2008) Literature review – methadone maintenance treatment. Public Works and Government Services Canada, Ottawa
Hubbard RL, Craddock SG, Anderson J (2003) Overview of 5-year follow-up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 25:126–134
INCB (2011) Report of the International Narcotic Control Board for 2011. http://www.incb.org/incb/en/publications/annual-reports/annual-report-2011.html
Kaya CY, Tugai Y, Filar JA, Agrawal MR, Ali RL, Gowing LR, Cooke R (2004) Heroin users in Australia: population trends. Drug Alcohol Rev 23:107–116
Klingemann H, Sobell LC (2007) Promoting self-change from addictive behaviors. Practical implications for policy, prevention and treatment. Springer, New York
Kramer JC (1977) Heroin in the treatment of morphine addiction. J Psychedelic Drugs 197:193–197
Leshner A (1997) Addiction is a brain disease, and it matters. Science 278:45–47
Marsh KL, Joe GW, Simpson DD, Lehmann WEK (1990) Treatment history. In: Simpson DD, Sells SB (eds) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar, pp 137–156
McLellan AT, Grissom GR, Zanis D, Randall M, Brill P, O’Brien CP (1997) Problem-service ‘matching’ in addiction treatment. A prospective study in 4 programs. Arch Gen Psychiat 54:730–735
Metzger DS, Woody GE, McLellan AT (1993) Human Immunodeficiency Virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 6:1049–1056
MHR (1995) Order from the Ministry of Health of Russia dated 14 August 1995 #239, titled About additional measures on control of narcotic drugs, dangerous substances and poisons
Miller N, Flaherty JA (2000) Effectiveness of coerced addiction treatment (alternative consequences) a review of the clinical research. J Subst Abuse Treat 18:9–16
Moyer A, Finney JW, Swearingen CE, Vergun P (2002) Brief interventions for alcohol problems: a meta-analytic review of controlled investigations into treatment-seeking and non-treatment-seeking populations. Addiction 97:279–292
NIDA (2012) Principles of drug addiction treatment. A research-based guide. National Institute of Drug Abuse, Bethesda
Rhodes T, Hedrich D (eds) (2010) Harm reduction: evidence, impact and challenges. EMCDDA Monograph. European Monitoring Centre for Drugs and Drug Addiction, Lisbon
Robins LN (1993) Vietnam veterans rapid recovery from heroin addiction – a fluke or normal expectation. Addiction 88:1041–1054
Rust A (2000) Ethische Aspekte. In: Uchtenhagen A, Zieglgänsberger W (eds) Suchtmedizin. Konzepte, Strategien und therapeutisches Management. Urban & Fischer, MĂ¼nchen, pp 573–584
Schumacher JE, Milby JB, Wallace D, Meehan DC, Kertesz S, Vuchinich R, Dunning J, Usdan S (2007) Meta-analysis of day treatment and contingency-management dismantling research: Birmingham homeless cocaine studies (1990–2006). J Consult Clin Psychol 75:823–828
Stallwitz A, Stoever H (2007) The impact of substitution treatment in prisons – a literature review. Int J Drug Policy 18:464–474
Stevens A, Hallam C, Trace M (2006) Treatment for dependent drug use. A guide for policymakers. Beckley Foundation, London
Tännsjö T (1999) Coercive care. The ethics of choice in health and medicine. Routledge, London
Uchtenhagen A (2003). Substitution management in opioid dependence. J Neurol Transmission, suppl 66: Fleischhacker WW, Brooks DJ (eds) Addictions, mechanisms, phenomenology and treatment, p 33–60
Uchtenhagen A (2010a) Treatment of substance dependence: ethical aspects. In: Helmchen H, Sartorius N (eds) Ethics in psychiatry – European contributions. Springer, Amsterdam, pp 381–400
Uchtenhagen A (2010b) Ethical perspectives in caring for people living with addictions: the European experience. Int Rev Psychiatry 22:274–280
Uchtenhagen A, GuggenbĂ¼hl L (2000) Adequacy in Drug Abuse Treatment and Care in Europe (ADAT). Commissioned by World Health Organisation, Regional Office for Europe. Research Institute for Public Health and Addiction, Zurich
Uchtenhagen A, Ladjevic T, Rehm J (2005) Guidelines for psychosocially assisted pharmacological treatment of persons dependent on opioids. Working paper for World Health Organisation. Research Institute for Public Health and Addiction, Zurich
UN (1948) Universal declaration of human rights. United Nations, New York
UN (1961) Single convention on narcotic drugs. United Nations, New York
UN (1971) Convention on psychotropic substances. United Nations, New York
UN (1988) United Nations convention against illicit traffic in narcotic drugs and psychotropic substances. United Nations, New York
UNODC/WHO/UNAIDS (2009) Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. United Nations Office on Drugs and Crime, Vienna
Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam
Weisner C (1990) Coercion in alcohol treatment. In: Institute of Medicine (ed) Broadening the base for the treatment of alcohol problems. The National Academic Press, Washington, DC, pp 579–610
Westermeyer J (1982) Poppies, pipes and people: opium and its use in Laos. University of California Press, Berkeley
Westermeyer J (2006) The switch from opium to heroin smoking. Addiction 92:686–687
WHO (2004a) Proposal for the inclusion of Methadone in the WHO model list of essential medicines. World Health Organisation, Geneva
WHO (2004b) Proposal for the inclusion of buprenorphine in the WHO model list of essential medicines. World Health Organisation, Geneva
WHO (2008) Guidelines for psychosocially assisted pharmacological treatments of opioid dependence. World Health Organisation, Geneva
WHO (2009) Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles. World Health Organisation, Manila
WHO (2010) International classification of diseases (10th ed) Version for 2010. World Health Organisation, WHO/UNODC (2008). Principles of drug dependence treatment. A discussion paper. World Health Organisation, Geneva
Wild DC, Cunningham JA, Ryan RM (2006) Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective. Addict Behav 31:1858–1872
Zinberg NE (1984) Drug, set and setting. Yale University Press, New Haven
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this entry
Cite this entry
Uchtenhagen, A. (2015). Ethical and Legal Aspects of Interventions in Addiction Treatment. In: el-Guebaly, N., CarrĂ , G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_65
Download citation
DOI: https://doi.org/10.1007/978-88-470-5322-9_65
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5321-2
Online ISBN: 978-88-470-5322-9
eBook Packages: MedicineReference Module Medicine